Clay B. Siegall - Dec 13, 2023 Form 3 Insider Report for Tourmaline Bio, Inc. (TRML)

Role: Director
Signature: /s/ Brad Middlekauff, Attorney-in-Fact
Stock symbol: TRML
Transactions as of: Dec 13, 2023
Transactions value $: $0
Form type: 3
Date filed: 12/15/2023, 04:21 PM
Previous filing: Oct 4, 2023
Next filing: Mar 8, 2024

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned